252 related articles for article (PubMed ID: 33081713)
1. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.
Yang M; Zhang Y; Zhao W; Cheng W; Wang H; Guo S
BMC Med Imaging; 2020 Oct; 20(1):119. PubMed ID: 33081713
[TBL] [Abstract][Full Text] [Related]
2. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.
Zhang W; Wang X; Miao Y; Hu C; Zhao W
Abdom Radiol (NY); 2018 Sep; 43(9):2262-2269. PubMed ID: 29476347
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system.
Takatsu Y; Kobayashi S; Miyati T; Shiozaki T
Eur J Radiol; 2016 Dec; 85(12):2206-2210. PubMed ID: 27842668
[TBL] [Abstract][Full Text] [Related]
4. Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI.
Ippolito D; Famularo S; Giani A; Orsini EB; Pecorelli A; Pinotti E; Gandola D; Romano F; Sironi S; Bernasconi DP; Gianotti L
Dig Liver Dis; 2019 Oct; 51(10):1438-1445. PubMed ID: 31153787
[TBL] [Abstract][Full Text] [Related]
5. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
[TBL] [Abstract][Full Text] [Related]
6. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
Kim HY; Choi JY; Park CH; Song MJ; Song DS; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE
J Gastroenterol; 2013 Oct; 48(10):1180-7. PubMed ID: 23354621
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
[TBL] [Abstract][Full Text] [Related]
8. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.
Tamada T; Ito K; Higaki A; Yoshida K; Kanki A; Sato T; Higashi H; Sone T
Eur J Radiol; 2011 Dec; 80(3):e311-6. PubMed ID: 21315529
[TBL] [Abstract][Full Text] [Related]
9. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.
Verloh N; Haimerl M; Rennert J; Müller-Wille R; Nießen C; Kirchner G; Scherer MN; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
Eur J Radiol; 2013 Oct; 82(10):1710-5. PubMed ID: 23806531
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study.
Li J; Cao B; Bi X; Chen W; Wang L; Du Z; Zhang X; Yu X
Radiol Med; 2021 Sep; 126(9):1149-1158. PubMed ID: 34105102
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Cui E; Long W; Luo L; Hu M; Huang L; Chen X
Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
[TBL] [Abstract][Full Text] [Related]
12. A novel method for evaluating enhancement using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid in the hepatobiliary phase of magnetic resonance imaging.
Takatsu Y; Kobayashi S; Miyati T; Shiozaki T
Clin Imaging; 2016; 40(6):1112-1117. PubMed ID: 27450444
[TBL] [Abstract][Full Text] [Related]
13. Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
BMC Med Imaging; 2017 Mar; 17(1):20. PubMed ID: 28249571
[TBL] [Abstract][Full Text] [Related]
14. The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease.
Cai S; Lin N; Yang Y; Ma W; Wang Y; Lin X; Wang X; Zhao X
Eur Radiol; 2023 May; 33(5):3425-3434. PubMed ID: 36897349
[TBL] [Abstract][Full Text] [Related]
15. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
Lin CY; Chang WC; Chou CT; Chen RC
J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
[TBL] [Abstract][Full Text] [Related]
16. Effect of type 2 diabetes on liver images of GD-EOB-DTPA-enhanced MRI during the hepatobiliary phase.
Zhang WY; Sun HY; Zhang WL; Feng R
Sci Rep; 2023 Jan; 13(1):543. PubMed ID: 36631556
[TBL] [Abstract][Full Text] [Related]
17. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
[TBL] [Abstract][Full Text] [Related]
18. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.
Haimerl M; Verloh N; Zeman F; Fellner C; Müller-Wille R; Schreyer AG; Stroszczynski C; Wiggermann P
PLoS One; 2013; 8(12):e85658. PubMed ID: 24392025
[TBL] [Abstract][Full Text] [Related]
19. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
[TBL] [Abstract][Full Text] [Related]
20. Visual criterion for evaluating hepatobiliary phase image acquisition of gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid-enhanced MRI.
Takatsu Y; Nakamura M; Kobayashi S; Miyati T
Clin Radiol; 2018 Aug; 73(8):760.e1-760.e6. PubMed ID: 29724434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
